Stocks Telegraph

BPMC Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:BPMC

Blueprint Medicines Corporation

$86.97
-0.61-0.70%
At Close 4:00 PM
$88.81
1.84+2.12%
After-Market 04:00 PM
62.9
BESG ScoreESG Rating

Stock Ratios

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

profit margin TTM
-56.64%
operating margin TTM
-98.12%
revenue TTM
259.44 Million
revenue per share TTM
4.1$

valuation ratios

pe ratio-27.03
peg ratio-0.27
price to book ratio17.35
price to sales ratio15.43
enterprise value multiple-14.20
price fair value17.35

profitability ratios

gross profit margin92.96%
operating profit margin-98.12%
pretax profit margin-56.49%
net profit margin-56.64%
return on assets-17.07%
return on equity-85.25%
return on capital employed-37.09%

liquidity ratio

current ratio3.71
quick ratio3.65
cash ratio0.22

efficiency ratio

days of inventory outstanding211.23
operating cycle296.80
days of payables outstanding69.39
cash conversion cycle227.42
receivables turnover4.27
payables turnover5.26
inventory turnover1.73

debt and solvency ratios

debt ratio0.55
debt equity ratio2.08
long term debt to capitalization0.63
total debt to capitalization0.67
interest coverage-8.26
cash flow to debt ratio-0.50

cash flow ratios

free cash flow per share-5.53
cash per share12.15
operating cash flow per share-5.30
free cash flow operating cash flow ratio1.04
cash flow coverage ratios-0.50
short term coverage ratios-2.90
capital expenditure coverage ratio-22.81

Frequently Asked Questions

When was the last time Blueprint Medicines Corporation (NASDAQ:BPMC) reported earnings?

Blueprint Medicines Corporation (BPMC) published its most recent earnings results on 01-08-2024.

What is Blueprint Medicines Corporation's current ROE?

An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Blueprint Medicines Corporation (NASDAQ:BPMC)'s trailing twelve months ROE is -85.25%.

What are ROA telling us?

The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Blueprint Medicines Corporation (BPMC) currently has a ROA of -17.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.

Where did BPMC's net profit margin stand at?

BPMC reported a profit margin of -56.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.

What is BPMC's short-term liquidity position?

Apple's current ratio, which measures its ability to pay short-term obligations, was 3.71 in the most recent quarter. The quick ratio stood at 3.65, with a Debt/Eq ratio of 2.08.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph